title: Erythema nodosum, a "red flag" during anti-TNF therapy.
authors.forename: Joan
authors.initials: J
authors.lastname: Dalmau-Carolà
mesh_terms: D000068879:Adalimumab; D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D004893:Erythema Nodosum / Q000175:diagnosis* / Q000209:etiology; D005260:Female; D006801:Humans; D008199:Lymphadenitis / Q000150:complications / Q000382:microbiology; D016896:Treatment Outcome; D014376:Tuberculosis / Q000150:complications / Q000382:microbiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab